Skip to main content

Table 1 Summary of studies reporting the frequency and mortality of sepsis and septic shock in China

From: Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis

Author

Year

Study design

No. of centers

Patients Location

Diagnosis Criteria

Sepsis mortality: cases/total number screened (%)

Septic shock mortality: cases/total number screened (%)

Severe sepsis mortality: cases/total number screened (%)

Study details

Cheng [22]

2007

Prospective

10

ICU

Sepsis-1

NA

NA

142/318 (44.7) (28-day)

Epidemiology of severe sepsis in critically ill surgical patients

Yang [23]

2007

Prospective

6

ICU

Sepsis-1

NA

NA

106/240 (44.2) (28-day)

Relationship between adrenal function and prognosis in patients with severe sepsis

Xie(24)

2008

Retrospective

10

ICU

Sepsis-1

NA

155/318 (30.5) (in-hospital)

NA

Impact of invasive fungal infection on outcomes of severe sepsis

Chen [25]

2009

Retrospective

1

ED

Sepsis-1

122/327 (37.3) (28-day)

NA

NA

Prognostic value of BNP in ED sepsis patients

Li [26]

2013

Prospective

11

ICU

Sepsis-2

NA

NA

72/218 (33.0) (28-day)

Implementing surviving sepsis campaign bundles in China

Wu [27]

2013

Prospective

6

ICU

Sepsis-1

NA

NA

110/361 (30.5) (28-day)

The efficacy of thymosin alpha 1 for severe sepsis

Wang [28]

2014

Prospective

1

ICU

Sepsis-1

87/196 (44.4) (28-day)

NA

NA

Functional polymorphisms of interferon-gamma affect

pneumonia-induced sepsis

Xu [29]

2014

Prospective

1

ICU

Sepsis-1

NA

9/58 (15.5) (28-day)

NA

Effect of two volume responsiveness evaluation methods on fluid resuscitation and prognosis in septic shock patients

Yin [30]

2014

Prospective

1

ED

Sepsis-2

225/680 (33.1) (28-day)

NA

NA

Thrombosis and haemostasias scoring system for overt disseminated intravascular coagulation in ED sepsis

Zhou [31]

2014

Prospective

22

ICU

Sepsis-1

NA

51/119 (42.9) [28-day]

162/484 (33.5) (28-day)

Epidemiology and Outcome of Severe Sepsis and Septic

Shock in Intensive Care Units

Luo [32]

2015

Prospective

1

ICU

Sepsis-1

NA

11/29 (38.0) (28-day)

NA

Increased cardiac index attenuates septic acute

kidney injury

Wu [33]

2015

Prospective

1

ICU

Sepsis-2

NA

NA

17/62 (27.4) (28-day)

Hypermetabolism is related to a poor outcome in Severe Sepsis

Li [34]

2016

Prospective

7

ICU

Sepsis-1

NA

48/199 (29.0) (28-day)

NA

Effects of Shenfu injection in the treatment of septic shock patients

Lu [35]

2016

Retrospective

1

ICU

Sepsis-2

NA

NA

18/68 (26.5) (28-day)

Peripheral T‑lymphocyte and NK cell imbalance is associated with septic encephalopathy

Cheng [36]

2017

Retrospective

6

ICU

Sepsis-1,

Sepsis-3

Sepsis-1: 58/186 (31.2) (28-day)

Sepsis-3: 58/175 (33.1) (28-day)

NA

NA

Comparison of the performance between sepsis-1 and sepsis-3 in ICUs in China

Wang [37]

2017

Prospective

1

ICU

Sepsis-3

NA

72/240 (30.0) [28-day]

NA

Effect of levosimendan on elderly septic shock patients

Yan [38]

2017

Prospective

1

ICU

Sepsis-2

NA

NA

30/63 (25.4) (28-day)

Prognostic value of left ventricular-arterial coupling in elderly patients with septic shock

Huang [39]

2018

Prospective

1

ED

Sepsis-1

4/39 (10.3) (28-day)

17/57 (29.8) [28-day]

8/55 (14.5) (28-day)

Lp‑PLA2 predict mortality rates of septic patients

Zhou [40]

2018

Prospective

1

ICU

Sepsis-2

74/178 (41.6) (in-hospital)

NA

NA

Impact of BMI on survival

of medical patients with sepsis

Liu [41]

2018

Prospective

21

ICU

Sepsis-2

NA

205/617 (33.2) (28-day)

NA

Terlipressin versus norepinephrine as infusion in patients with septic shock

Jiang [42]

2019

Retrospective

1

Hospital-wide

Sepsis-3

19/98 (19.4) (28-day)

NA

NA

Analysis of prognostic

factors of septic pulmonary embolism patients

Liang [43]

2019

Retrospective

1

ICU

Sepsis-3

NA

146/232 (62.9) (28-day)

NA

Prognostic factors of mortality in

Septic patients with mechanically ventilation

Xing [44]

2019

Prospective

5

ICU

Sepsis-1

58/301 (19.3) (28-day)

NA

NA

Traditional Chinese medicine bundle therapy for septic acute

gastrointestinal injury

Xue [45]

2019

Prospective

1

ICU

Sepsis-1

NA

NA

18/71 (25.4) (28-day)

Alterations of Th2/Th1 in previously immunocompetent patients with community-acquired severe sepsis

Zhang W [13]

2019

Prospective

1

ICU

Sepsis-3

188/631 (29.8) (28-day)

NA

NA

Systemic inflammatory response syndrome

in Sepsis-3

Zhang Z [46]

2019

Retrospective

1

ICU

Sepsis-2

473/1997 (23.7) (in-hospital)

NA

NA

Prolonged stay in ED increased risk of hospital mortality in septic patients

Dong [14]

2020

Retrospective

111

Hospital-wide

Sepsis-1,

Sepsis-3

Sepsis-1: 353/1716 (20.6) (in-hospital)

Sepsis-3: 299/935 (32.0) (in-hospital)

NA

NA

External validity of Adult Sepsis Event’s simplified SOFA criteria

Xie [8]

2020

Prospective

44

ICU

Sepsis-1

824/2322 (35.5) (90-day)

NA

NA

The epidemiology of sepsis in Chinese ICUs

Zhao [47]

2020

Retrospective

2

ED

Sepsis-3

95/316 (30.1) (28-day)

NA

NA

Serum ammonia levels for predicting

sepsis patient mortality